← Open Payments lookup

DEEPA HASIJA: Open Payments

NPI 1801107040 · LAS VEGAS, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$552 in 24 payments from 7 companies in 2025. Trend: 2023 $152 · 2024 $201 · 2025 $552

Food & beverage: $552
CompanyPaymentsAmount
ABBVIE INC.8$169
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)7$163
Otsuka America Pharmaceutical, Inc.4$103
E.R. Squibb & Sons, L.L.C.2$46
Janssen Pharmaceuticals, Inc1$28
Teva Pharmaceuticals USA, Inc.1$28
Takeda Pharmaceuticals U.S.A., Inc.1$16

Products named: VRAYLAR, CAPLYTA, REXULTI, COBENFY, SPRAVATO, AUSTEDO XR, ABILIFY ASIMTUFII, TRINTELLIX.

Industry payments across NV — which companies pay providers there.